Close Menu

Human Subjects (IRB)

IRB Submissions

All submissions to the IRB are routed through Cayuse IRB. To create an Initial Submission, access Cayuse IRB by following these steps listed in this document. (Cayuse IRB Instructions)

If you do not have access to Cayuse IRB, please send an email to drichard1@iit.edu  

Human Subject Training

IIT requires all individuals involved in the conduct of human subjects research to complete initial human subjects protection training. IRB approval will be withheld if these training requirements have not been met.

These requirements apply to all persons with a significant role in the research, such as:

  • Principal Investigators, Co-investigators, other IIT researchers, non-affiliates, and
  • Individuals who will obtain informed consent from prospective participants in research or analyze data that have participant identifiers.

NOTE: Responsible Conduct of Research (RCR) courses DO NOT satisfy the human subject training requirement.

The human subjects courses available through CITI that satisfy the requirement are: Social & Behavioral Research Investigators and Biomedical Research Investigators. These courses are listed under Question 1 during the CITI registration process (see #7 below under NEW CITI REGISTRANTS and #4 under RETURNING CITI REGISTRANTS).

Initial Training

CITI Program is IIT's exclusive provider of research compliance and ethics training. CITI courses may be accessed through the myIIT portal. To complete required human subjects training, complete the steps given in this document through CITI. (CITI Directions)

Previous Training

If training was completed at another institution, please send a PDF of the training certificate to irb@iit.edu to determine whether it meets IIT’s training requirements.

Recertification

Recertification is required every 3 years.

Please note that a CITI refresher course may fulfil this requirement up to 3 times, and then the CITI basic course will be required at the next recertification.

Institutional Review Board (IRB) Meetings and Deadlines

Please review the IRB submission deadlines and full committee meeting dates below. NOTE: these dates apply for IRB applications that require full committee review only. Exempt and Expedited applications are reviewed on a rolling basis.

Fall 2022 Meetings and Deadlines

Deadline for Submission

IRB Meeting Date

Time

November 3, 2022

November 17, 2022

12:50 PM

December 1, 2022

December 15, 2022

12:50 PM

Spring and Summer 2023 Meetings and Deadlines

Deadline for Submission

IRB Meeting Date

Time

January 5, 2023

January 19, 2023

12:50 PM

February 2, 2023

February 16, 2023

12:50 PM

March 2, 2023

March 16, 2023

12:50 PM

April 6, 2023

April 20, 2023

12:50 PM

May 4, 2023

May 18, 2023

12:50 PM

June 1, 2023

June 15, 2023

12:50 PM

SUBMISSION DEADLINE

Deadline for submission is 5:00 pm on the date indicated. If you miss the deadline, your IRB submission will be reviewed at the following scheduled meeting. If your project is reviewed by the full committee, you must attend the IRB meeting to present your application. Your presentation should be 3 - 5 minutes long. No additional materials are necessary.

If no IRB applications are received for a scheduled meeting and there are no administrative issues to be discussed, the meeting will be canceled.

Clinical Trials

NIH Definition

Note: The NIH defines "clinical trial" broadly. Please review the NIH Notice of Revised Definition of "Clinical Trial" for more information.

Not sure if your study is defined as a "clinical trial?" Access the NIH clinical trial decision tool.

If your study qualifies as a "clinical trial," you must register your study on the website, ClinicalTrials.gov, which is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. Based on the new definition of a "clinical trial," your study may be affected by these regulations, even if you are not conducting the study in a clinical setting. The NIH website provides a summary of the new definition to help investigators determine if their study qualifies as a "clinical trial."

FDA Definition

Section 801 of the Food and Drug Amendments Act, known as FDAAA 801, requires registration of studies meeting the definition of "Applicable Clinical Trial" on the website ClinicalTrials.gov.

To obtain a login/password to access ClinicalTrials.gov for your IIT study, please submit the Request Form. Note that IIT's Organization name is "IllinoisIT" for this website.

More information on the federal requirement for clinical trials is here.

Decision Tools

Decision Tool: Am I Doing Human Subjects Research? | grants.nih.gov

Research Involving Private Information or Biospecimens - Decision Tree

Decision Tool: Is my study defined as a "clinical trial?" Access the NIH clinical trial decision tool.

Is My Research "HUman SUbjects" Research?

If you are unsure if your research involves "human subjects" as defined by the federal regulations, the Definitions of Human Subject Research will help you.

Research involving private information or biological specimens provided by an outside source (such as a commercial provider) may be considered "human subjects" research. Consult the decision tree to determine if your project is considered "human subjects" research. Note that the IRB still bears the final responsibility in determining whether a research project is considered "human subjects" research or otherwise exempt.

For research protocols funded by the NIH, if you answered "No" to the question "Are Human Subjects Involved?" additional resources are available on the NIH Grants website. If you need additional assistance with grant proposals, please contact the Office of Sponsored Research and Programs.

WEB

Office for Human Research Protections (OHRP)
http://www.hhs.gov/ohrp/
Code of Federal Regulations, Protections of Human Subjects (45 CFR 46)
https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html 
The Belmont Report:
https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html

VIDEO

"Protecting Human Subjects" - click the links below to view each video

Important Links

NEW RESOURCE FOR INVESTIGATORS

The Investigator Manual below is a comprehensive resource for investigators to prepare research proposals for review by the IRB. The Manual is in continual development and the link will be updated as necessary.

Please direct any questions, queries or comments to irb@iit.edu.

IIT Investigator Manual

IIT Handbook of Procedures for the Protection of Human Research Subjects

Contacts

IRB Chair: Indika Edirisinghe iedirisi@iit.edu.
IRB Office: irb@iit.edu.

IIT's federal wide assurance number is 00001463

Human Protections Information From OHRP

The Office for Human Research Protections (OHRP) encourages all members within the research/IRB community to consult with OHRP staff on matters of human subject protections.
The toll-free number for OHRP is 866.447.4777.

Click here for a list of OHRP staff.